Carib A. Oquendo

Array ( [id] => 9581693 [patent_doc_number] => 08771694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells' [patent_app_type] => utility [patent_app_number] => 09/988013 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 10757 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 259 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 09988013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 295767 [patent_doc_number] => 07541034 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-06-02 [patent_title] => 'Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors' [patent_app_type] => utility [patent_app_number] => 09/381497 [patent_app_country] => US [patent_app_date] => 1998-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 16844 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/541/07541034.pdf [firstpage_image] =>[orig_patent_app_number] => 09381497 [rel_patent_id] =>[rel_patent_doc_number] =>)